Home

MORGAN STANLEY INVESTMENT MANAGEMENT INC

CIK 1230193 · last filed 2015-01-26

MORGAN STANLEY INVESTMENT MANAGEMENT INC is a corporate insider who has filed 5 SEC Form 4 insider transactions across 1 company since 2013. The most recent filing shows the insider sold $10.9M of SGNT on Jan 26, 2015. Across all open-market trades the lifetime net is −$20.0M, making them a net seller over the disclosed history. The firm reports its address in New York, NY. 25 SEC filings were submitted jointly with MORGAN STANLEY AIP GP LP.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

5

Lifetime Open-Market Net

-$20.01M

Filer Profile

Reported Address
1221 AVENUE OF THE AMERICAS
NEW YORK, NY 10020
Phone
(212) 761-4000
Related Filers
MORGAN STANLEY AIP GP LP — 25 joint filings, latest 2015-01-28
MORGAN STANLEY GLOBAL EMERGING MARKETS INC — 8 joint filings, latest 2006-05-19
Cowen Holdings, Inc. — same reported address
JP MORGAN SBIC HOLDINGS LLC — same reported address
MSDW Venture Partners IV, LLC — same reported address
SIRIUS XM HOLDINGS INC. — same reported address
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Sagent Pharmaceuticals, Inc. (SGNT) Delisted 10%+ Owner 3,225,093 — — -$20.01M 5 2015-01-26

Recent Filings

5 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2015-01-26 Sagent Pharmaceuticals, Inc. (SGNT) Delisted Sell (S) −423,766 -$10.85M EDGAR
2013-10-07 Sagent Pharmaceuticals, Inc. (SGNT) Delisted Sell (S) −95,652 -$1.94M EDGAR
2013-10-03 Sagent Pharmaceuticals, Inc. (SGNT) Delisted Sell (S) −19,960 -$443.8K EDGAR
2013-09-27 Sagent Pharmaceuticals, Inc. (SGNT) Delisted Sell (S) −135,930 -$2.77M EDGAR
2013-09-20 Sagent Pharmaceuticals, Inc. (SGNT) Delisted Sell (S) −177,770 -$4.00M EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.